WELL Health Technologies (WELL.TO) reported that its second quarter net income attributable to owners declined to C$12.15 million from C$103.69 million, prior year. Earnings per share was C$0.05 compared to C$0.41. Adjusted net income increased to C$25.77 million from C$4.08 million. Adjusted net income per share was C$0.10 compared to C$0.02. Second quarter revenue increased C$356.67 million from C$227.31 million, previous year.
The company reaffirmed its 2025 annual guidance for revenue. Also, the company increased guidance for annual adjusted EBITDA to be in the upper half of its previously provided guidance of C$190 million to C$210 million. Excluding the impact of CM Deferrals, the company is improving its guidance for annual adjusted EBITDA to be in the upper half of its previously provided guidance of C$140 million to C$160 million.
For more earnings news, earnings calendar, and earnings for stocks, visit rttnews.com.
For comments and feedback contact: editorial@rttnews.com
Business News
June 19, 2026 16:46 ET Major central banks continued to dominate the economic news flow this week too, led by the Federal Reserve, as they announced their latest policy decisions. The Federal Reserve policy session was in focus as it was the first to be led by the new chief Kevin Warsh. In Europe, central banks of the U.K. and Switzerland announced their rate decisions. In Asia, the Bank of Japan drew attention for its policy moves, while data out of China threw some light on the state of the economy.